HealthStream, Inc. (HSTM) Expected to Post Quarterly Sales of $61.98 Million

Wall Street brokerages expect HealthStream, Inc. (NASDAQ:HSTM) to post $61.98 million in sales for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for HealthStream’s earnings, with the highest sales estimate coming in at $63.10 million and the lowest estimate coming in at $61.10 million. HealthStream reported sales of $58.74 million in the same quarter last year, which indicates a positive year-over-year growth rate of 5.5%. The business is expected to report its next quarterly earnings report on Tuesday, February 20th.

According to Zacks, analysts expect that HealthStream will report full-year sales of $61.98 million for the current year, with estimates ranging from $246.00 million to $248.00 million. For the next fiscal year, analysts anticipate that the business will report sales of $267.75 million per share, with estimates ranging from $263.56 million to $271.70 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow HealthStream.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings results on Monday, October 23rd. The technology company reported $0.08 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.03. The business had revenue of $63.60 million during the quarter, compared to the consensus estimate of $62.48 million. HealthStream had a net margin of 2.36% and a return on equity of 2.46%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.04 earnings per share.

Several equities analysts have commented on the stock. Robert W. Baird dropped their price target on shares of HealthStream from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, October 25th. Needham & Company LLC downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a research note on Wednesday, October 25th. ValuEngine upgraded shares of HealthStream from a “sell” rating to a “hold” rating in a research note on Wednesday, January 3rd. Canaccord Genuity restated a “hold” rating and issued a $25.00 price target on shares of HealthStream in a research note on Monday, October 23rd. Finally, Zacks Investment Research downgraded shares of HealthStream from a “hold” rating to a “sell” rating in a research note on Wednesday, January 3rd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $24.83.

HealthStream (NASDAQ HSTM) opened at $24.53 on Friday. The company has a market cap of $776.99, a price-to-earnings ratio of 136.29, a price-to-earnings-growth ratio of 5.14 and a beta of 0.91. HealthStream has a 12 month low of $21.81 and a 12 month high of $31.53.

Several institutional investors have recently added to or reduced their stakes in HSTM. Janus Henderson Group PLC purchased a new stake in shares of HealthStream during the 2nd quarter worth $23,186,000. Conestoga Capital Advisors LLC lifted its position in shares of HealthStream by 17.2% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,755,050 shares of the technology company’s stock worth $40,647,000 after purchasing an additional 257,400 shares during the last quarter. Emerald Mutual Fund Advisers Trust purchased a new stake in shares of HealthStream during the 3rd quarter worth $5,643,000. FMR LLC lifted its position in shares of HealthStream by 2.5% during the 2nd quarter. FMR LLC now owns 4,733,510 shares of the technology company’s stock worth $124,586,000 after purchasing an additional 116,309 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of HealthStream by 4.0% during the 2nd quarter. Vanguard Group Inc. now owns 2,324,958 shares of the technology company’s stock worth $61,193,000 after purchasing an additional 89,220 shares during the last quarter. 74.48% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “HealthStream, Inc. (HSTM) Expected to Post Quarterly Sales of $61.98 Million” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2018/01/28/healthstream-inc-hstm-expected-to-post-quarterly-sales-of-61-98-million.html.

About HealthStream

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Get a free copy of the Zacks research report on HealthStream (HSTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply